Address: | 2719 Lakecrest Dr, Pearland, TX 77584, USA |
---|---|
Postal code: | 77584 |
Phone: | (713) 745-5266 |
Website: | https://faculty.mdanderson.org/profiles/anil_sood.html |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Sood Anil K, use the form below and your opinion, advice or comment will appear in this space.
Get directions, reviews and information for M D Anderson Cancer Center in Pearland, TX.
As is shown in our records this property is placed at 2719 Lakecrest Drive, Pearland, Texas. This property has 4,475 square feet of habitable area and sits on near a half of acre.
On 1734-2735 Lakecrest Dr, Pearland TX we have 26 property listings for the 155 residents and businesses. ... Sood Anil K (713) 745-5266: Categories: Government ...
Find 7 listings related to Dr Sood in Houston on YP.com. See reviews, photos, directions, phone numbers and more for Dr Sood locations in Houston, TX.
Sood Anil K. 2719 Lakecrest Dr Pearland, TX 77584 (713) 745-5266. General Contractors Building Specialties. Website. Add to mybook Remove from mybook. Added to your ...
We know 24 properties and 88 residents on 2706+ Lakecrest Dr, Pearland TX. Discover property public reports, residents, sales and rent history, real estate value and risk factors.
Abstract. Tumor development and progression are inherently dependent on the process of angiogenesis. Recently, anti-angiogenic therapy has started to show promise as an effective treatment strategy in many solid tumors including ovarian carcinoma.
The Neuroendocrine Impact of Chronic Stress on Cancer and neurotransmitters, which are increased in certain biobehavioral states on the multistep process of cancer metastasis. In order to proliferate, tumor cells rely on nutrient and oxygen diffusion. The effects of stress-related hormones on tumor cell prolif-
We found 50 matches for A Sood Age range: 31-91. Results in 130 cities, 43 phone numbers, 191 addresses. Full background check available. View Now.
Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy despite several~decades of progress in diagnosis and treatment. Taking advantage of the robust development of discovery and utility of prognostic biomarkers, clinicians